With the help of prescription medications and a whole lot of moisturizing, it’s possible to keep dermatitis under control.

According to Statifacts, the global allergy diagnostic market size is calculated at USD 6,711 million in 2025 and is expected ...

For children with atopic dermatitis, early childhood stressful life events are associated with an increased risk for disease activity.

Individuals on immunosuppressants should discontinue them prior to patch testing, if at all possible, to avoid tarnishing the test results, according to updated guidelines from the North American ...

More information about the 2025 AAAAI / WAO Joint Congress can be accessed here.

China's NMPA has granted approval for Keymed Biosciences’ supplemental NDA of Stapokibart to treat seasonal allergic rhinitis ...

Abstract Title: Briquilimab Potently Inhibits Stem Cell Factor (SCF)/c-Kit Signaling and Induces Mast Cell Apoptosis Poster Number: 541 Session Title: Novel Mechanisms of Mast Cells, Basophils and IgE ...

Nektar Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for rezpegaldesleukin for the treatment of adult and pediatric patients 12 years ...

FOOD allergies (FA) affect millions of children worldwide, causing severe allergic reactions, including anaphylaxis.

CHENGDU, China I 8, 2025 I Keymed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has ...